Pharma Cos Urged To Innovate And Not Imitate

Mumbai, December 21: | Updated: Dec 22 2002, 05:30am hrs
Indian pharma companies need to focus on innovation and not imitation to promote a bigger cause among the developing and less-developed countries. This could be achieved considering the immense talent in the scientific field available in this country and would benefit the less-developed countries along with India, Council of Scientific and Industrial Research (CSIR), director-general Dr RA Mashelkar said.

He was addressing the 41st annual general meeting of the Indian Drug Manufacturers Association (IDMA) here on Saturday. Dr Mashelkar is also the member of UK Commission on Intellectual Property Rights (IPR). IPR laws should be such that meet the development needs of the country, he said.

Dr Mashelkar emphasised on the need for proper balance between pharmaceutical patent rights, public health requirements, local economy and technological development and reduction of poverty in developing countries.